WATERTOWN, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL) (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative ...
WATERTOWN, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback